As health care prices continue to grow unabated in the commercial market, millions of Americans face premium increases and greater exposure to out-of-pocket costs through deductibles, co-insurance, and other expenses. Such commercial prices paid to providers are far higher and have been rising more quickly than the prices paid by public health insurance programs, like Medicare. Various policy initiatives under consideration could help address this dynamic, while certain actions (including litigation) by the health care industry could further worsen the problem.
More Issues
- 340B Program 15 cases
- Affordable Care Act 64 cases
- Anticompetitive Practices 18 cases
- Artificial Intelligence 3 cases
- Consumer Protections 10 cases
- Equity 42 cases
- ERISA 12 cases
- Federal Health Funding 18 cases
- Health Information 2 cases
- Medicare Advantage 5 cases
- Medicare Drug Price Negotiation 19 cases
- No Surprises Act 30 cases
- Prescription Drug Affordability 15 cases
- Reproductive Health 38 cases
- Site-Neutral Payments 10 cases
- Transparency 5 cases